NCT07206069 Telemedicine to Support Living Kidney Donor Candidates
| NCT ID | NCT07206069 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, Irvine |
| Condition | Healthy |
| Study Type | INTERVENTIONAL |
| Enrollment | 70 participants |
| Start Date | 2026-05-04 |
| Primary Completion | 2026-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 70 participants in total. It began in 2026-05-04 with a primary completion date of 2026-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this feasibility clinical trial is to learn if telemedicine can be used to provide education and evaluation and counseling for people who are considering living kidney donation. The study will also learn how participants improve decision-making about living kidney donation. The main questions to answer are: * Is telemedicine a practical way to facilitate donor education and evaluation and counseling? * Does telemedicine shared decision making help improve donor candidate decision and engagement during the donor evaluation process? Researchers will compare standard care with a telemedicine care coordination approach. Participants will: \- Receive either standard care or telemedicine video visits to support shared decision making.
Eligibility Criteria
Inclusion Criteria: * 18 years of age or older * Reside in the State of California * Registered living kidney donor candidate at UC Irvine Medical Center Exclusion Criteria: \- Individuals with a contraindication to living kidney donation (for example, heart disease, cancer)
Contact & Investigator
Fawaz Al Ammary, MD PhD
PRINCIPAL INVESTIGATOR
University of California, Irvine
Frequently Asked Questions
Who can join the NCT07206069 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Healthy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07206069 currently recruiting?
Yes, NCT07206069 is actively recruiting participants. Contact the research team at fawaz.alammary@uci.edu for enrollment information.
Where is the NCT07206069 trial being conducted?
This trial is being conducted at Orange, United States.
Who is sponsoring the NCT07206069 clinical trial?
NCT07206069 is sponsored by University of California, Irvine. The principal investigator is Fawaz Al Ammary, MD PhD at University of California, Irvine. The trial plans to enroll 70 participants.